Athira Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	91.22	96.39	110.54	60.63	2.06	3.32
Short-Term Investments	56.84	104.38	143.22	124.06	0.01	1.51
Cash & Cash Equivalents	148.05	200.76	253.76	184.68	2.06	4.82
Cash Growth	-26.26%	-20.88%	37.40%	8852.11%	-57.23%	-
Receivables	0	1.23	2.34	1.3	0	0
Other Current Assets	6.68	5.54	4.7	6.36	0.1	0.07
Total Current Assets	154.73	207.53	260.8	192.34	2.16	4.9
Property, Plant & Equipment	4.44	5.32	5.22	3.59	0	0
Long-Term Investments	0	44.83	65.94	83.51	0.03	0.04
Other Long-Term Assets	1.08	0.48	0.06	0.13	0	0
Total Long-Term Assets	5.52	50.62	71.21	87.23	0.03	0.04
Total Assets	160.25	258.15	332.01	279.56	2.19	4.93
Accounts Payable	0.13	2.5	0.57	1.16	0.42	0.12
Current Debt	0.37	0.33	0.29	0.12	0	0
Other Current Liabilities	28.34	18.6	8.44	3.12	0.85	0.45
Total Current Liabilities	28.84	21.43	9.29	4.41	1.27	0.57
Long-Term Debt	1.22	1.59	1.63	0.88	1.55	0.72
Other Long-Term Liabilities	0	0	0	0	2.04	1.48
Total Long-Term Liabilities	1.22	1.59	1.63	0.88	3.59	2.2
Total Liabilities	30.06	23.02	10.92	5.28	4.86	2.77
Total Debt	1.59	1.91	1.92	1	1.55	0.72
Debt Growth	-17.06%	-0.47%	92.00%	-35.61%	115.10%	-
Retained Earnings	-309.21	-191.53	-95.9	-41.04	-21.09	-15.93
Comprehensive Income	-0.35	-1.96	-0.39	0.03	0	0
Shareholders' Equity	130.19	235.14	321.08	274.28	-19.72	-14.89
Net Cash / Debt	146.47	198.85	251.84	183.68	0.51	4.1
Net Cash / Debt Growth	-26.35%	-21.04%	37.11%	35916.08%	-87.56%	-
Net Cash Per Share	3.85	5.27	6.82	15.35	0.14	1.18
Working Capital	125.89	186.1	251.51	187.93	0.89	4.33
Book Value Per Share	3.42	6.23	8.70	22.92	-5.53	-4.29

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).